FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileBetaShares - Global Healthcare Currency Hedged ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
DRUG.AX
BetaShares - Global Healthcare Currency Hedged ETF ETF AnalysisComprehensive ETF analysis for BetaShares - Global Healthcare Currency Hedged ETF (DRUG.AX) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisDRUG.AX
DRUG.AX
BetaShares - Global Healthcare Currency Hedged ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
DRUG.AX
  1. Home
  2. Screener
  3. BetaShares - Global Healthcare Currency Hedged ETFDRUG.AXETF
BetaShares - Global Healthcare Currency Hedged ETF Logo

BetaShares - Global Healthcare Currency Hedged ETF

ETF
🇦🇺DRUG.AX•ASX•Equity

Your view on DRUG.AX

BetaShares - Global Healthcare Currency Hedged ETF Logo

BetaShares - Global Healthcare Currency Hedged ETF

ETFBetaShares
🇦🇺DRUG.AX•ASX•Equity
AUM (AUD)$193.74M
Expense Ratio0.57%
Yield (TTM)3.96%
Holdings0

Sentiment

—

AUM (AUD)

$193.74M

Expense Ratio

0.57%

Yield (TTM)

3.96%

Holdings

0

Sentiment

—
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

BetaShares - Global Healthcare Currency Hedged ETF (DRUG.AX) is an Equity fund from BetaShares, listed since 2016, with $193.7M in assets under management, a 0.57% expense ratio and a NAV of $9.51 AUD.

Overview for BetaShares - Global Healthcare Currency Hedged ETF

Fund Type
ETF
Fund Issuer
BetaShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
August 4, 2016
Domicile
AU
Website
betashares.com.au/fund/global-healthcare-etf-currency-hedged
Fund Type
ETF
Fund Issuer
BetaShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
August 4, 2016
Domicile
AU
Website
betashares.com.au/fund/global-healthcare-etf-currency-hedged
Fund Type
ETF
Fund Issuer
BetaShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
August 4, 2016
Domicile
AU
Website
betashares.com.au/fund/global-healthcare-etf-currency-hedged

About this fund

This ETF seeks to replicate the returns of a specific index (prior to any fees or charges) that comprises prominent global healthcare firms located outside of Australia. Its currency exposure is managed by hedging the investments into Australian dollars.

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Equity

Expense Ratio

0.57%

Yield (TTM)

3.96%

AUM

$193.74M

Fund Details

NAV$9.51 AUD
Average Volume128.0K
Inception DateAugust 4, 2016
Asset ClassEquity
Fund IssuerBetaShares
DomicileAU
ISINAU00000DRUG1
NAV CurrencyAUD

Expense Ratio

0.57%

Dividend Yield (TTM)

3.96%

Assets Under Management

$193.74M

NAV

$9.51 AUD

Average Volume

128.0K

Inception Date

August 4, 2016

Asset Class

Equity

Fund Issuer

BetaShares

Domicile

AU

ISIN

AU00000DRUG1

NAV Currency

AUD

Expense Ratio

0.57%

Dividend Yield (TTM)

3.96%

Assets Under Management

$193.74M

NAV

$9.51 AUD

Average Volume

128.0K

Inception Date

August 4, 2016

Asset Class

Equity

Fund Issuer

BetaShares

Domicile

AU

ISIN

AU00000DRUG1

NAV Currency

AUD

Distributions · last 12 months

Semi-Annual · 2 payments

Ex-datePaidAmount
Jul 1, 2026Jul 16, 2026$0.3121
Jan 2, 2026Jan 19, 2026$0.0344
Total, 12 months$0.35 a share

Dividend yield (TTM) 3.96% = $0.35 paid per share in the 12 months to Nov 20, 2026 ÷ the $8.76 price. Past distributions; future payments can differ.

Data last updated: Nov 19, 2026, 08:12 AM

Sectors

How the fund's assets are split across sectors.

1 sectors
  • 1Healthcare
    100.0%

Top sector

Healthcare

Top weight

100.0%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

66 positions
1LLYELI LILLY & CO
9.14%
2JNJJOHNSON & JOHNSON
7.85%
3ABBVABBVIE INC
6.98%
4MRKMERCK & CO INC
4.69%
5UNHUNITEDHEALTH GROUP INC
4.34%
6AZN.LASTRAZENECA PLC
4.21%
7ROP.SWROCHE HOLDING AG
4.19%
8NOVN.SWNOVARTIS AG
3.91%
9TMOTHERMO FISHER SCIENTIFIC INC
3.85%
10AMGNAMGEN INC
3.18%
11GILDGILEAD SCIENCES INC
2.98%
12ABTABBOTT LABORATORIES
2.57%
13DHRDANAHER CORP
2.29%
14PFEPFIZER INC
2.27%
15ISRGINTUITIVE SURGICAL INC
2.11%

Concentration

Total Holdings66
Top 10 Weight52.33%
Top HoldingLLY
Top Weight9.14%
1LLYELI LILLY & CO
9.14%
2JNJJOHNSON & JOHNSON
7.85%
3ABBVABBVIE INC
6.98%
4MRKMERCK & CO INC
4.69%
5UNHUNITEDHEALTH GROUP INC
4.34%
6AZN.LASTRAZENECA PLC
4.21%
7ROP.SWROCHE HOLDING AG
4.19%
8NOVN.SWNOVARTIS AG
3.91%
9TMOTHERMO FISHER SCIENTIFIC INC
3.85%
10AMGNAMGEN INC
3.18%
11GILDGILEAD SCIENCES INC
2.98%
12ABTABBOTT LABORATORIES
2.57%
13DHRDANAHER CORP
2.29%
14PFEPFIZER INC
2.27%
15ISRGINTUITIVE SURGICAL INC
2.11%

Total Holdings

66

Top 10 Weight

52.33%

Top Holding

LLY

Top Weight

9.14%

1LLYELI LILLY & CO
9.14%$18.51M
2JNJJOHNSON & JOHNSON
7.85%$15.89M
3ABBVABBVIE INC
6.98%$14.13M
4MRKMERCK & CO INC
4.69%$9.51M
5UNHUNITEDHEALTH GROUP INC
4.34%$8.78M
6AZN.LASTRAZENECA PLC
4.21%$8.53M
7ROP.SWROCHE HOLDING AG
4.19%$8.48M
8NOVN.SWNOVARTIS AG
3.91%$7.91M
9TMOTHERMO FISHER SCIENTIFIC INC
3.85%$7.80M
10AMGNAMGEN INC
3.18%$6.44M
11GILDGILEAD SCIENCES INC
2.98%$6.03M
12ABTABBOTT LABORATORIES
2.57%$5.21M
13DHRDANAHER CORP
2.29%$4.63M
14PFEPFIZER INC
2.27%$4.61M
15ISRGINTUITIVE SURGICAL INC
2.11%$4.28M

Total Holdings

66

Top 10 Weight

52.33%

Top Holding

LLY

Top Weight

9.14%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on19 funds
FundAsset classExpense ratioAssetsHoldings
DRUG.AXBetaShares - Global Healthcare Currency Hedged ETFThis fundEquity0.57%$194M0

Comparable funds

  • BNKS.AXBetaShares - Global Banks Currency Hedged ETFEquity0.57%$192M0
  • FUEL.AXBetashares Global Energy Companies Currency Hedged ETFEquity0.57%$262M0
  • HJPN.AXBetaShares - Japan Currency Hedged ETFEquity0.56%$319M0
  • IKO.AXiShares MSCI South Korea ETFEquity0.45%$154M74
  • ISO.AXiShares S&P/ASX Small Ordinaries ETFEquity0.55%$120M205
  • IXI.AXiShares Global Consumer Staples ETF (AU)Equity0.41%$148M1
  • MNRS.AXBetaShares - Global Gold Miners Currency Hedged ETFEquity0.57%$222M0
  • NDIA.AXGlobal X India Nifty 50 ETFEquity0.69%$197M0

More BetaShares ETFs

  • AAA.AXBetaShares - Australian High Interest Cash ETFEquity0.18%$5.2B0
  • AGVT.AXBetaShares - Australian Government Bond ETFFixed Income0.22%$1.2B0
  • ARMR.AXBetaShares - Global Defence ETFEquity0.55%$216M0
  • ASIA.AXBetaShares - Asia Technology Tigers ETFEquity0.67%$1.1B0
  • AUDS.AXBetashares Strong Australian Dollar Fund (Hedge Fund)Alternatives1.38%$19M0
  • AUST.AXBetaShares - Managed Risk Australian Shares Complex ETFEquity0.49%$26M0
  • BBOZ.AXBetaShares Australian Equities Strong Bear Complex ETFLeveraged/Inverse1.29%$170M0
  • BBUS.AXBetaShares - US Equities Strong Bear Currency Hedged Complex ETFLeveraged/Inverse1.32%$119M0
  • BEAR.AXBetaShares - Australian Equities Bear Complex ETFLeveraged/Inverse1.48%$32M0
  • BHYB.AXBetaShares - Australian Major Bank Hybrids Index ETFFixed Income0.35%$681M0
  • BNDS.AXBetaShares Western Asset Australian Bond Active ETFFixed Income0.42%$881M0
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.

News

Latest Market News

News

Latest Market News